Ranbaxy and Cipla rejoice as US clears 2 more anti-anthrax drugs
The anthrax scare in the US has finally opened up a window of opportunity for Ranbaxy and Cipla. The US administration has announced that antibiotics other than ciprofloxacin-principally doxycycline